BRCA

Maureen (Molly) Welch-Marahar (MPP '17) submits this internship field report from her summer 2016 service with Breast Cancer Action in San Francisco, California. I’m one month into my 10 weeks here at Breast Cancer Action and I already feel at home....

“Before we get too excited about the possibility of giving everyone access to potentially life-saving information, we need to remember that the relationship between the BRCA genes and cancer incidence is complex and fraught with uncertainty,” writes...

The American Civil Liberties Union (ACLU) recently filed a petition asking the U.S. Supreme Court to review a decision upholding patents on human genes BRCA1 and BRCA2. The Court will soon decide the case involving Myriad Genetics, Inc., which owns...

In honor of National Cancer Survivors Day Shobita Parthasarathy was interviewed by the MIT Press about cancer research and health care advances. In the Q&A format blog post, Parthasarathy spoke about gene patenting—specifically BRCA 1 and BRCA 2,...

Shobita Parthasarathy was interviewed by German Public Radio about recent debates on the legality of patenting human genes. Since a narrowly decided Supreme Court ruling in the 1980s, the U.S. Patent Office has allowed patents for a variety of life...